Management of hemorrhagic events in patients receiving anticoagulant therapy.
Love
D G
DG
Instructor in Medicine, Harvard University, Cambridge, Massachusetts.
D000925:Anticoagulants / Q000009:adverse effects*; D016913:Blood Component Transfusion; D004347:Drug Interactions; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology / Q000628:therapy*; D006493:Heparin / Q000009:adverse effects*; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D010949:Plasma; D017713:Platelet Transfusion; D017410:Practice Guidelines as Topic; D011479:Protamines / Q000627:therapeutic use; D012307:Risk Factors; D014812:Vitamin K / Q000627:therapeutic use*; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D006494:Heparin Antagonists; D011479:Protamines; D014812:Vitamin K; D014859:Warfarin; D006493:Heparin